Clinical Trial Update: Prophylactic Application of Donor-derived TCM After Allogeneic HSCT [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial investigated prophylactic use of donor-derived TCM after allogeneic hematopoietic stem cell transplantation, completed by Würzburg Un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia Myeloid Acute
• Myelodysplastic Syndromes

Snippet

Sponsor: Wuerzburg University Hospital | Conditions: Leukemia, Myeloid, Acute, Myelodysplastic Syndromes | Phase 1, Phase 2 | Status: COMPLETED